Advertisement
Advertisement
U.S. markets open in 49 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Guardion Health Sciences, Inc. (GHSI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.1543-0.0007 (-0.45%)
At close: 04:00PM EDT
0.1500 -0.00 (-2.79%)
Pre-Market: 08:32AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Williams %R

Williams %R

Previous Close0.1550
Open0.1600
Bid0.1500 x 900
Ask0.1543 x 1200
Day's Range0.1480 - 0.1639
52 Week Range0.1380 - 1.9800
Volume1,852,328
Avg. Volume7,797,763
Market Cap9.478M
Beta (5Y Monthly)0.77
PE Ratio (TTM)N/A
EPS (TTM)-0.8780
Earnings DateAug 15, 2022 - Aug 19, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.60
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for GHSI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Guardion Health Sciences, Inc.
    Analyst Report: Zimmer Biomet Holdings, Inc.Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Close to 60% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products; the remaining portion is primarily related to spine and dental products.
    Rating
    Fair Value
    Economic Moat
    6 months agoMorningstar
View more
  • GlobeNewswire

    Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2022

    Viactiv® Generated Net Revenues of approximately $2.3 Million or 95% of Net Revenues for the Quarter Ended March 31, 2022HOUSTON, May 12, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based, clinically-supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients, announced its financial results for the quarter e

  • GlobeNewswire

    Guardion Health Sciences to Present at the Planet MicroCap Showcase 2022

    HOUSTON, May 03, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements, announces today that Chief Executive Officer Bret Scholtes will present a corporate overview at the Planet MicroCap Showcase 2022. The conference is being held on May 3 – 5, 2022 at The Bally’s Hotel & Casino in Las Vegas, NV. Presentation Date:May 4, 2022 Time:5:00pm Pacific Time Webcast Link:https://w

  • ACCESSWIRE

    Keynotes, Educational Panels and 88 Companies to Present at the Planet MicroCap Showcase on May 3-5, 2022 at Bally's Hotel & Casino in Las Vegas, NV

    LOS ANGELES, CA / ACCESSWIRE / April 27, 2022 / SNN Network presents the Planet MicroCap Showcase taking place on May 3-5, 2022, where 88 MicroCap public and private companies will be presenting at Bally's Hotel & Casino in Las Vegas, NV.comThe Planet MicroCap Showcase begins on Tuesday, May 3, 2022 with the "MicroCap Investing Workshop" starting at 12:00pm PST and featuring well-known financial influencers, investors, fund managers, and key opinion leaders, followed by 88 MicroCap public and pr

Advertisement
Advertisement